CALC
Income statement / Annual
Last year (2023), CalciMedica, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, CalciMedica, Inc.'s net income was -$34.36 M.
See CalciMedica, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$58,000.00
|
$52,000.00
|
$519,000.00
|
$395,000.00
|
$303,000.00
|
$175,000.00
|
| Gross Profit |
-$58,000.00
|
-$52,000.00
|
-$519,000.00
|
-$395,000.00
|
-$303,000.00
|
-$175,000.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$12.36 M
|
$14.11 M
|
$18.90 M
|
$20.96 M
|
$30.58 M
|
$22.97 M
|
| General & Administrative Expenses |
$0.00
|
$19.10 M
|
$17.04 M
|
$8.87 M
|
$6.92 M
|
$5.60 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.46 M
|
$19.10 M
|
$17.04 M
|
$8.87 M
|
$6.92 M
|
$5.60 M
|
| Other Expenses |
$0.00
|
$2.96 M
|
$0.00
|
$2.16 M
|
$72,000.00
|
$0.00
|
| Operating Expenses |
$21.82 M
|
$33.22 M
|
$35.95 M
|
$29.83 M
|
$37.50 M
|
$28.57 M
|
| Cost And Expenses |
$21.88 M
|
$33.22 M
|
$35.95 M
|
$29.83 M
|
$37.50 M
|
$28.57 M
|
| Interest Income |
$0.00
|
$575,000.00
|
$126,000.00
|
$143,000.00
|
$393,000.00
|
$192,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$126,000.00
|
$143,000.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$58,000.00
|
$52,000.00
|
$519,000.00
|
$395,000.00
|
$303,000.00
|
$175,000.00
|
| EBITDA |
-$34.19 M |
-$7.64 M |
-$35.30 M |
-$27.14 M |
-$36.73 M |
-$28.20 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$12.48 M
|
$28.36 M
|
$126,000.00
|
$2.30 M
|
$465,000.00
|
$192,000.00
|
| Income Before Tax |
-$34.36 M
|
-$35.61 M
|
-$35.82 M
|
-$27.53 M
|
-$37.04 M
|
-$28.38 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$109,895.00
|
$2.39 M
|
-$2.00 M
|
-$538,000.00
|
-$393,000.00
|
$13,859.00
|
| Net Income |
-$34.36 M
|
-$35.61 M
|
-$35.82 M
|
-$27.53 M
|
-$37.04 M
|
-$28.38 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-7.65 |
-23.2 |
-23.66 |
-58.24 |
-35.85 |
-33.1 |
| EPS Diluted |
-7.65 |
-23.2 |
-23.66 |
-58.24 |
-35.85 |
-33.1 |
| Weighted Average Shares Out |
$4.49 M
|
$1.53 M
|
$1.51 M
|
$472,746.00
|
$1.03 M
|
$857,282.00
|
| Weighted Average Shares Out Diluted |
$4.49 M
|
$1.53 M
|
$1.51 M
|
$472,746.00
|
$1.03 M
|
$857,282.00
|
| Link |
|
|
|
|
|
|
